Lynbrook (United States)

Type: City
Name: Lynbrook (United States)
Country: United States
Latitude: 40.66
Longitude: -73.669998
population: 19,626
First reported 18 hours ago - Updated 9 hours ago - 1 reports

BioSpecifics Technologies Corp. Announces FDA Approval of sBLA for XIAFLEX® for the Concurrent Treatment of Two Dupuytren's Contracture Cords

LYNBROOK, N.Y., Oct. 21, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the ... [Published PR Newswire: Policy & Public Interest - 18 hours ago]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

BioSpecifics Technologies Corp. Announces Presentation of Encouraging Preclinical Data for CCH from Collaborative Uterine Fibroid Study with Duke Medicine

LYNBROOK, N.Y., Oct. 16, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the ... [Published PR Newswire: Health - Oct 16 2014]
First reported Oct 11 2014 - Updated Oct 11 2014 - 1 reports

Lynbrook school's likely to OK Gold Star Exemption

Herald file photoLocal veterans, many of whom marched in this year’s Memorial Day parade in Lynbrook, were displeased with the school board decision not to allow district servicemen and women a tax exemption.School taxes in Lynbrook may be increasing ... [Published LIHerald.com - Oct 11 2014]
First reported Oct 08 2014 - Updated Oct 08 2014 - 1 reports

BioSpecifics Technologies Corp. Announces Sudden Passing of Director Max Link, Ph.D.

LYNBROOK, N.Y. , Oct. 8, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. ( NASDAQ: BSTC ), today announced with great sadness that Max Link , Ph.D., a member of its Board of Directors, passed away unexpectedly on October 5, 2014 . He was 74 years ... [Published Town Hall - Oct 08 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Mutual of Omaha Retirement Services Hiring

By a News Reporter-Staff News Editor at Insurance Weekly News -- Mutual of Omaha Retirement Services is hiring in response to expected sales of 401(k) Admin Advantage SM, an ERISA section 3(16) administrative support and fiduciary service option for Mutual ... [Published HispanicBusiness.com - Sep 25 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 2 reports

BioSpecifics Technologies : to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference

LYNBROOK, N.Y., Sept. 19, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) in the U.S. and XIAPEX(®) in the EU, announced today ... [Published 4 Traders - Sep 19 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

BioSpecifics Technologies Corp. Announces New MULTICORD and Retreatment Data for XIAFLEX® for Dupuytren's Contracture Presented at American Society for Surgery of the Hand Annual Meeting

LYNBROOK, N.Y., Sept. 18, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ... [Published PR Newswire: General Business - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Lynbrook comes together for 9/11 remembrance

Maureen Lennon/HeraldThe Lynbrook Fire Department stood at attention during the ceremonyThe Village of Lynbrook’s elected officials and residents alike came out last Thursday to honor and remember the victims of terrorist attacks of Sept. 11, 2001.The ... [Published LIHerald.com - Sep 18 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences

LYNBROOK, N.Y., Sept. 2, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, announced today that ... [Published PR Newswire: Health - Sep 02 2014]
First reported Aug 21 2014 - Updated Aug 22 2014 - 1 reports

BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite

LYNBROOK, N.Y., Aug. 21, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ... [Published PR Newswire: Health - Aug 21 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 1 reports

BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results

LYNBROOK, N.Y., Aug. 11, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ... [Published PR Newswire: Financial Services - Aug 11 2014]
First reported Aug 04 2014 - Updated Aug 05 2014 - 1 reports

BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014

LYNBROOK, N.Y., Aug. 4, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ... [Published PR Newswire: Health - Aug 04 2014]

Quotes

...it is estimated that 35 to 40 percent of Dupuytren's surgeries treat more than one cord," commented Thomas L Wegman , President of BioSpecifics. "In addition to growth from the expanded label, we also look forward to broadening the commercial reach of XIAFLEX into markets outside the U S with the potential approval in Japan for Dupuytren's contracture and in the EU for Peyronie's disease. With all of these avenues to reach new patients with XIAFLEX, we expect to see continued commercial success through 2015."
...products marketed as XIAFLEX ® (collagenase clostridium histolyticum or CCH) in the U S and XIAPEX ® in the EU, announces that a paper titled, "Stiffness of Human Uterine Fibroids is Reduced After Treatment with Purified Clostridial Collagenase due to Collagen Degradation" was presented at the Mechanotransduction in the Reproductive Tract conference hosted by the Campion Fund of the Phyllis and Mark Leppert Foundation for...
...It was a privilege to have him on our Board," said Thomas L Wegman , President of BioSpecifics. "I, along with all of our employees and the Board of Directors, extend our deepest sympathies to his family and close friends."
"Mutual of Omaha has responded with a cost-effective solution," he said. "With 401(k) Admin Advantage SM, business owners not only save time and effort completing the required administrative duties, Mutual of Omaha also accepts the fiduciary liability for services rendered."

More Content

All (27) | News (12) | Reports (0) | Blogs (15) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
BioSpecifics Technologies Corp. Announces FDA A... [Published Myrtle Beach Sun News - 18 hours ago]
BioSpecifics Technologies Corp. Announces FDA A... [Published PR Newswire: Policy & Public Interest - 18 hours ago]
BioSpecifics Technologies Corp. Announces Prese... [Published Fat Pitch Financials - Oct 16 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published Stock Nod - Oct 16 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: Health - Oct 16 2014]
Lynbrook school's likely to OK Gold Star Exemption [Published LIHerald.com - Oct 11 2014]
BioSpecifics Technologies Corp. Announces Sudde... [Published Town Hall - Oct 08 2014]
Eyeing the ocular vitamin aisle [Published Eye World - Oct 03 2014]
Mutual of Omaha Retirement Services Hiring [Published HispanicBusiness.com - Sep 25 2014]
BioSpecifics Technologies : to Present at the 2... [Published 4 Traders - Sep 19 2014]
BioSpecifics Technologies Corp. to Present at t... [Published PR Newswire: General Business - Sep 19 2014]
BioSpecifics Technologies Corp. Announces New M... [Published PR Newswire: General Business - Sep 18 2014]
Lynbrook comes together for 9/11 remembrance [Published LIHerald.com - Sep 18 2014]
Healthcare Finance Group, LLC Leads the Financi... [Published Franklin Credit Management Corporation - Sep 17 2014]
Mutual of Omaha Retirement Services Hiring [Published Scottrade - Sep 16 2014]
Bethpage Federal Credit Union Commits To Long I... [Published Prlog - Sep 12 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: Health - Sep 02 2014]
BioSpecifics Technologies Corp. Announces Posit... [Published PR Newswire: Health - Aug 21 2014]
BioSpecifics Technologies Corp. Reports Second ... [Published PR Newswire: Financial Services - Aug 11 2014]
BioSpecifics Technologies Corp. Announces Initi... [Published PR Newswire: Health - Aug 08 2014]
BioSpecifics Technologies Corp. to Host Confere... [Published PR Newswire: Health - Aug 04 2014]
BioSpecifics Technologies Corp. to Be Added to ... [Published PR Newswire: Health - Jun 27 2014]
BioSpecifics Technologies Corp. Announces Filin... [Published PR Newswire: Health - Jun 25 2014]
BioSpecifics Announces New Analyses of XIAFLEX ... [Published PR Newswire: Health - May 19 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: General Business - May 12 2014]
BioSpecifics Technologies Corp. Reports First Q... [Published PR Newswire: Health - May 08 2014]
BioSpecifics Technologies Corp. to Host Confere... [Published PR Newswire: Health - May 01 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BioSpecifics Technologies Corp. Announces FDA A... [Published PR Newswire: Policy & Public Interest - 18 hours ago]
LYNBROOK, N.Y., Oct. 21, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the ...
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: Health - Oct 16 2014]
LYNBROOK, N.Y., Oct. 16, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the ...
BioSpecifics Technologies Corp. to Present at t... [Published PR Newswire: General Business - Sep 19 2014]
LYNBROOK, N.Y., Sept. 19, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, announced today that ...
BioSpecifics Technologies Corp. Announces New M... [Published PR Newswire: General Business - Sep 18 2014]
LYNBROOK, N.Y., Sept. 18, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ...
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: Health - Sep 02 2014]
LYNBROOK, N.Y., Sept. 2, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, announced today that ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.